Clinical trial
A Multicenter, Open-Label, Interventional Study to Evaluate Subject Satisfaction of AbobutulinumtoxinA Treatments in Moderate to Severe Glabellar Lines
NCT03687736 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-Label, Interventional Study to Evaluate Subject Satisfaction of AbobutulinumtoxinA Treatments in Moderate to Severe Glabellar Lines
- Lead sponsor
- Galderma R&D
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 2, 2018
- Completion date
- December 4, 2019
- Enrollment
- 120 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
glabellar frown lines